Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: A one-year follow-up study

Acta Dermato-Venereologica

Volumn 79, Issue 3, 1999, Pages 204-206

  Soler, Ana Maria ^a   Warloe, Trond ^a   TausjØ, Johan ^a   Berner, Aasmund ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

5 aminolevulinic acid; Curettage; Dimethylsulphoxide; Nodular basal cell carcinoma; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CURETTAGE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CARCINOMA; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANTI-INFLAMMATORY AGENTS; BIOPSY; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CURETTAGE; DIMETHYL SULFOXIDE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECURRENCE; SEVERITY OF ILLNESS INDEX; SKIN; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033011563     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750010977     Document Type: Article

References (15)

1. 1. Dougerthy TJ. Photosensitisation of malignant tumours. Semin Surg Oncol 1986; 2: 24-37.
2. 2. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992; 128: 1597-1601.
3. 3. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B: Biol 1990; 6: 143-148.
4. 4. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitisation and laser irradiation. Br J Dermatol 1994; 130: 743-751.
5. 5. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993; 128: 17-21.
6. 6. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol 1995; 133: 282-288.
7. 7. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 1995; 287: 665-674.
8. 8. Peng Q, Warloe T, Heyerdahl H, Moan J, Steen HB, Giercksky K.-E. Distribution of 5-aminolevulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. J Photochem Photobiol 1995; 62: 906-913.
9. 9. Warloe T, Peng Q, Moan J, Steen HB, Nesland JM, Giercksky K.-E. Photodynamic therapy with 5-aminolevulinic acid induced and DMSO/EDTA for basal cell carcinoma. SPIE 2371, 1994: 226-235.
10. 10. Warloe T, Heyerdahl H, Giercksky K.-E. Curettage and topical ALA-based photodynamic therapy for nodular ulcerative basal cell carcinomas. Thesis. ISBN 82-7722-038-3, 1995; paper VI. University of Oslo.
11. 11. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clinics Dermatol 1995; 13: 617-620.
12. 12. Olbricht SM. Treatment of malignant cutaneous tumors. Dermatol Plastic Surg 1993; 20: 167-180.
13. 13. Rowe DE, Carroll RJ, Day CL Jr. Long term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patients follow-up. J Dermatol Surg Oncol 1989; 15: 315-328.
14. 14. Peng Q, Moan J, Warloe T, Iani V, Steen HB, Bjørseth, Nesland JM. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B: Biol 1995; 34: 95-96.
15. 15. Kloek J, Beijersbergen van Henegouwen GMJ. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. J Photochem Photobiol B: Biol 1996; 6: 994-1000.